RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | 332.06% | 308.65% | 1,941.80% | 485.26% | -66.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 332.06% | 308.65% | 1,941.80% | 485.26% | -66.28% |
| Cost of Revenue | 373.40% | 346.78% | 1,798.06% | 631.61% | -71.04% |
| Gross Profit | 134.87% | 186.77% | 4,601.32% | -1,097.06% | 57.04% |
| SG&A Expenses | 44.48% | 94.40% | 83.81% | 334.13% | 207.24% |
| Depreciation & Amortization | 436.05% | 612.93% | 712.04% | -16.52% | 647.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.53% | 98.82% | 140.64% | 263.19% | 31.01% |
| Operating Income | -4.94% | -32.35% | -16.28% | -232.47% | -373.79% |
| Income Before Tax | -246.69% | 8.12% | -218.77% | -132.06% | -126.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -246.69% | 8.12% | -218.77% | -132.06% | -126.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -246.69% | 8.12% | -218.77% | -132.06% | -126.31% |
| EBIT | -4.94% | -32.35% | -16.28% | -232.47% | -373.79% |
| EBITDA | 15.25% | -10.09% | 4.06% | -231.57% | -360.82% |
| EPS Basic | -134.66% | 64.56% | -2.17% | 24.86% | -106.12% |
| Normalized Basic EPS | -13.50% | -5.17% | -13.90% | 5.80% | 6.32% |
| EPS Diluted | -134.66% | 64.56% | -2.17% | 24.86% | -108.48% |
| Normalized Diluted EPS | -13.50% | -5.17% | -13.90% | 5.80% | -28.11% |
| Average Basic Shares Outstanding | 47.89% | 159.07% | 212.19% | 209.22% | 329.33% |
| Average Diluted Shares Outstanding | 47.89% | 159.07% | 212.19% | 209.22% | 213.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |